Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019

臓器移植検査の世界市場:血清学的検査、混合リンパ球培養試験(MLC)、ポリメラーゼ連鎖反応(PCR)、次世代シーケンシング(NGS)

◆タイトル:Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019
◆商品コード:MAM-BT-3266
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年3月25日
◆ページ数:157
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、臓器移植検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、製品別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

The global transplant diagnostics market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of ~645.0 Million in 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the transplant diagnostics market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period. The growth of the transplant diagnostics market is driven by factors such as growing geriatric population, coupled with an increasing population base for chronic disease patients, technological advancement in the field of HLA typing, increased public-private investments to develop innovative HLA testing products, rising number of solid organ, soft tissue, and stem cell-based transplantation procedures across the world. However, factors such as high cost of PCR and NGS instruments and limited medical reimbursement available for transplantation procedures are restraining the growth of this market. Huge gap between number of organs donated and organ donations required annually across the globe is posing a significant challenge for the growth of the transplant diagnostics market.

In this report, the global transplant diagnostics market has been segmented on the basis of type of technology (molecular and non-molecular assay), type of product (instruments, reagents and consumables, and software and services), type of end users (hospitals and transplant centers, research laboratories and academic institutes, and commercial service providers) and type of application (diagnostic and research applications). The molecular assay technology segment accounted for the largest share of the global transplant diagnostics market in 2014, followed by the non-molecular assay technology market. Factors such as technological advancements in the field of HLA typing, rising adoption of HLA typing in research and medical diagnosis, benefits offered by robotics in lab automation, and increasing installation base of PCR and NGS instruments are driving the growth of transplant diagnostics market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global transplant diagnostics market in 2014, followed by Europe. The transplant diagnostics market in the North America is primarily driven by factors such as increase in public and private funding for development of HLA typing technology, growing number of solid organ transplantation procedure, and continuous reduction in average cost of gene sequencing. However, financial constraints faced by market players are limiting the growth of the digital transplant diagnostics market in this region. The Asia-Pacific region is poised to grow at the highest CAGR during next five years, owing to factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel HLA typing technologies, and strengthening healthcare infrastructure across the region.

The global transplant diagnostics market is moderately competitive with a various global as well as local market players. As of 2013, the global transplant diagnostics market was dominated by Thermo Fisher Scientific Inc. (U.S.), Immucor, Inc. (U.S.), Olerup Ssp Ab (Norway), Qiagen N.V. (Netherlands), Bio-Rad Laboratories Inc. (U.S.), and Abbott Laboratories Inc. (U.S.), which together accounted for ~89.0% of the market. New product launches, partnerships, agreements, and collaborations, and strategic acquisitions are the major strategies adopted by most of the market players to achieve growth in the global transplant diagnostics market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis — industry analysis (industry trends and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the transplant diagnostics market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on transplant diagnostics products offered by the top 10 players in the global transplant diagnostics market. The report analyzes the transplant diagnostics market by type of product, technology, end user, and application across key geographic region

• Product Development/Innovation: Detailed insights on upcoming HLA typing technologies, research and development activities, and new product launches in the global transplant diagnostics market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transplant diagnostics products across key geographic region

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global transplant diagnostics market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global transplant diagnostics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 GEOGRAPHIC SCOPE 17
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key industry insights 22
2.1.2.3 Breakdown of Primaries 22
2.2 MARKET SIZE ESTIMATION 23
2.2.1 BOTTOM-UP APPROACH 23
2.2.2 TOP-DOWN APPROACH 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 RESEARCH ASSUMPTIONS 26
2.4.1 ASSUMPTIONS 26

3 EXECUTIVE SUMMARY 27
3.1 INTRODUCTION 27
3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO 28
3.3 FUTURE OUTLOOK 29
3.4 CONCLUSION 31

4 PREMIUM INSIGHTS 32
4.1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, 2014–2019 32
4.2 GLOBAL TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET, BY REGION (2014–2019) 33
4.3 TRANSPLANT DIAGNOSTIC PRODUCTS AND SERVICES MARKET, BY REGION (2014) 34
4.4 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER (2014–2019) 35
4.5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION (2014–2019) 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 38
5.2.2 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT 38
5.2.3 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 39
5.2.4 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 39
5.3 MARKET DYNAMICS 39
5.3.1 DRIVERS 40
5.3.1.1 Rising number of solid organ, soft tissue, and stem cell transplantation procedures 40
5.3.1.2 Technological advancements in HLA typing 41
5.3.1.3 Growing geriatric population 42
5.3.2 RESTRAINTS 43
5.3.2.1 High cost of PCR and NGS instruments 43
5.3.2.2 Huge gap between number of organs donated and required annually 43
5.3.2.3 Limited medical reimbursements available for transplantation procedures 44
5.3.3 OPPORTUNITIES 44
5.3.3.1 Growing market penetration in emerging countries 44
5.3.3.2 Technological shift from serological assays to genome-based HLA profiling 45

6 INDUSTRY TRENDS 47
6.1 INTRODUCTION 47
6.2 VALUE CHAIN ANALYSIS 47
6.3 PORTER’S FIVE FORCES ANALYSIS 48
6.3.1 THREAT FROM NEW ENTRANTS 49
6.3.2 THREAT FROM SUBSTITUTES 50
6.3.3 BARGAINING POWER OF SUPPLIERS 50
6.3.4 BARGAINING POWER OF BUYERS 51
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 51

7 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 52
7.1 INTRODUCTION 53
7.2 MOLECULAR ASSAYS 54
7.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED 56
7.2.1.1 Sequence-specific Primer PCR (SSP-PCR) 56
7.2.1.2 Sequence-specific oligonucleotide PCR (SSO-PCR) 57
7.2.2 SEQUENCING-BASED ASSAYS 58
7.2.2.1 Sanger sequencing 59
7.2.2.2 Next-generation sequencing (NGS) 59

7.3 NON-MOLECULAR ASSAYS 60
7.3.1 SEROLOGICAL ASSAYS 62
7.3.2 MIXED LYMPHOCYTE CULTURE (MLC) ASSAYS 63

8 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 65
8.1 INTRODUCTION 66
8.2 REAGENTS AND CONSUMABLES 67
8.3 INSTRUMENTS 68
8.4 SOFTWARE AND SERVICES 69

9 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 71
9.1 INTRODUCTION 72
9.2 HOSPITALS AND TRANSPLANT CENTERS 73
9.3 COMMERCIAL SERVICE PROVIDERS 74
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 75

10 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 77
10.1 INTRODUCTION 78
10.2 DIAGNOSTIC APPLICATIONS 79
10.3 RESEARCH APPLICATIONS 80

11 TRANSPLANT DIAGNOSTICS MARKET, BY REGION 81
11.1 INTRODUCTION 82
11.2 NORTH AMERICA 83
11.2.1 U.S. 84
11.2.2 CANADA 86
11.3 EUROPE 88
11.3.1 GERMANY 89
11.3.2 U.K. 91
11.3.3 FRANCE 93
11.3.4 REST OF EUROPE 94
11.4 ASIA-PACIFIC 97
11.4.1 JAPAN 98
11.4.2 CHINA 100
11.4.3 INDIA 102
11.4.4 REST OF ASIA-PACIFIC 104
11.5 REST OF THE WORLD 106

12 COMPETITIVE LANDSCAPE 108
12.1 OVERVIEW 108
12.2 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 108
12.3 COMPETITIVE SCENARIO 110
12.4 RECENT DEVELOPMENTS 111
12.4.1 MERGERS AND ACQUISITIONS 111
12.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 113
12.4.3 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 114
12.4.4 GEOGRAPHICAL EXPANSION 115
12.4.5 OTHER DEVELOPMENTS 116

13 COMPANY PROFILES 117
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 INTRODUCTION 117
13.2 THERMO FISHER SCIENTIFIC, INC. 120
13.3 IMMUCOR, INC. 125
13.4 OLERUP SSP AB 128
13.5 QIAGEN N.V. 130
13.6 BIO-RAD LABORATORIES, INC. 134
13.7 ABBOTT LABORATORIES, INC. 138
13.8 ILLUMINA, INC. 142
13.9 LINKAGE BIOSCIENCES, INC. 145
13.10 FUJIREBIO EUROPE N.V. 148
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

14 APPENDIX 149
14.1 INSIGHTS OF INDUSTRY EXPERTS 149
14.2 DISCUSSION GUIDE 150
14.3 COMPANY DEVELOPMENTS 154
14.3.1 THERMO FISHER SCIENTIFIC 154
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 155
14.5 AVAILABLE CUSTOMIZATIONS 155
14.6 RELATED REPORTS 156

LIST OF TABLES

TABLE 1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012–2019 ($MILLION) 53
TABLE 2 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR MOLECULAR ASSAYS,
BY TYPE, 2012–2019 ($MILLION) 54
TABLE 3 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 55
TABLE 4 GLOBAL TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2012–2019 ($MILLION) 56
TABLE 5 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SSP-PCR-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 57
TABLE 6 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SSO-PCR-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 58
TABLE 7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2012–2019 ($MILLION) 58
TABLE 8 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SANGER SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 59
TABLE 9 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR NGS-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 60
TABLE 10 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR NON-MOLECULAR ASSAYS, BY TYPE, 2012–2019 ($MILLION) 61
TABLE 11 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR NON-MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 61
TABLE 12 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SEROLOGICAL ASSAY-BASED NON-MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 63
TABLE 13 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR MLC ASSAY-BASED NON-MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION) 63
TABLE 14 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 66
TABLE 15 TRANSPLANT DIAGNOSTICS REAGENTS AND CONSUMABLES MARKET SIZE,
BY REGION, 2012-2019 ($MILLION) 68
TABLE 16 TRANSPLANT DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 69
TABLE 17 TRANSPLANT DIAGNOSTICS SOFTWARE AND SERVICES MARKET SIZE,
BY REGION, 2012-2019 ($MILLION) 70
TABLE 18 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 72
TABLE 19 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION, 2012–2019 ($MILLION) 74
TABLE 20 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2012–2019 ($MILLION) 75
TABLE 21 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2012–2019 ($MILLION) 76
TABLE 22 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 78
TABLE 23 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2012–2019 ($MILLION) 79
TABLE 24 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR RESEARCH APPLICATIONS,
BY REGION, 2012–2019 ($MILLION) 80
TABLE 25 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 82
TABLE 26 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 84
TABLE 27 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 84
TABLE 28 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 85
TABLE 29 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 85
TABLE 30 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 85
TABLE 31 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 86
TABLE 32 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 86
TABLE 33 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 87
TABLE 34 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 87
TABLE 35 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 89
TABLE 36 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 90
TABLE 37 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 90
TABLE 38 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 90
TABLE 39 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 91
TABLE 40 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 91
TABLE 41 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 92
TABLE 42 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 92
TABLE 43 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 92
TABLE 44 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 93
TABLE 45 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 93
TABLE 46 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 94
TABLE 47 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 94
TABLE 48 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 95
TABLE 49 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 95
TABLE 50 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 96
TABLE 51 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 96
TABLE 52 ASIA-PACIFIC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 98
TABLE 53 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 99
TABLE 54 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 99
TABLE 55 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 100
TABLE 56 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 100
TABLE 57 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 101
TABLE 58 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 101
TABLE 59 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 101
TABLE 60 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 102
TABLE 61 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 103
TABLE 62 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 103
TABLE 63 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 103
TABLE 64 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 104
TABLE 65 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 104
TABLE 66 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 105
TABLE 67 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 105
TABLE 68 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 105
TABLE 69 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 106
TABLE 70 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 106
TABLE 71 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 107
TABLE 72 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 107
TABLE 73 TOP MERGERS AND ACQUISITIONS, 2012–2014 111
TABLE 74 TOP AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2014 113
TABLE 75 TOP NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012–2014 114
TABLE 76 TOP GEOGRAPHICAL EXPANSIONS, 2012–2014 115
TABLE 77 TOP OTHER DEVELOPMENTS, 2012–2014 116


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BOTTOM-UP APPROACH 23
FIGURE 3 TOP-DOWN APPROACH 24
FIGURE 4 DATA TRIANGULATION 25
FIGURE 5 ASSUMPTIONS OF THE RESEARCH STUDY 26
FIGURE 6 THE U.S. AND GERMANY TO DRIVE THE REVENUE GROWTH IN TRANSPLANT DIAGNOSTICS MARKET TILL 2019 27
FIGURE 7 SSP- & SSO-PCR ASSAY TECHNIQUES TO LEAD REVENUE GROWTH IN TRANSPLANT DIAGNOSTIC MARKET DURING THE FORECAST PERIOD 29
FIGURE 8 TRANSPLANT DIAGNOSTICS MARKET SHARE, BY REGION, 2014 30
FIGURE 9 THERMO FISHER HOLDS LEADERSHIP POSITION IN THE TRANSPLANT DIAGNOSTIC MARKET (2014) 31
FIGURE 10 MARKET GROWTH WILL BE DRIVEN BY TECHNOLOGICAL ADVANCEMENTS, RISING GERIATRIC POPULATION 32
FIGURE 11 MOLECULAR ASSAY TECHNOLOGY TO LEAD REVENUE GROWTH ACROSS KEY REGIONS IN THE TRANSPLANT DIAGNOSTICS MARKET 33
FIGURE 12 NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE TRANSPLANT DIAGNOSTICS PRODUCTS MARKET IN 2014 34
FIGURE 13 HOSPITALS AND TRANSPLANT CENTERS TO BE THE FASTEST-GROWING END-USER SEGMENT DURING THE FORECAST PERIOD 35
FIGURE 14 U.S. AND GERMANY TO LEAD THE MARKET DEMAND FOR TRANSPLANT DIAGNOSTICS APPLICATIONS 36
FIGURE 15 BY TECHNOLOGY 38
FIGURE 16 BY PRODUCT 38
FIGURE 17 BY END USER 39
FIGURE 18 BY APPLICATION 39
FIGURE 19 GROWING NUMBER OF TRANSPLANTATION PROCEDURES DRIVING GLOBAL DEMAND FOR TRANSPLANT DIAGNOSTIC PROCEDURES 40
FIGURE 20 BURGEONING NUMBER OF TRANSPLANTATIONS GIVING A STRONG FILLIP TO U.S. MARKET GROWTH 41
FIGURE 21 PREVALENCE OF LUNG CANCER WILL BE HIGHEST IN GERIATRIC POPULATION 43
FIGURE 22 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010-2012) 45
FIGURE 23 VALUE CHAIN ANALYSIS (2013): MAJOR VALUE IS ADDED DURING R&D PHASE 48
FIGURE 24 RISING NUMBER OF NEW ENTRANTS IN THE TRANSPLANT DIAGNOSTICS FIELD IS STIMULATING MARKET COMPETITION 49
FIGURE 25 MOLECULAR ASSAYS ARE THE LARGEST SEGMENT IN THE TRANSPLANT DIAGNOSTIC TECHNOLOGY MARKET 54
FIGURE 26 PCR TECNIQUES ARE DRIVING THE OVERALL GROWTH OF THE MOLECULAR ASSAYS TECHNOLOGY SEGMENT 55
FIGURE 27 SEROLOGICAL ASSAYS SEGMENT IS DRIVING THE REVENUE GROWTH OF NON-MOLECULAR TRANSPLANT DIAGNOSTIC TECHNOLOGY MARKET 62
FIGURE 28 REAGENTS AND CONSUMABLES SEGMENT COMMANDED LARGEST SHARE OF THE GLOBAL TRANSPLANT DIAGNOSTICS MARKET 67
FIGURE 29 HOSPITALS AND TRANSPLANT CENTERS IS THE FASTEST-GROWING END-USER SEGMENT DURING THE FORECAST PERIOD 73
FIGURE 30 DIAGNOSTIC APPLICATIONS TO CONTRIBUTE TO THE HIGHEST OVERALL REVENUE GROWTH DURING 2014–2019 78
FIGURE 31 NORTH AMERICA ACCOUNTED FOR MORE THAN 37% SHARE OF THE GLOBAL TRANSPLANT DIAGNOSTICS MARKET IN 2014 83
FIGURE 32 EUROPE: A MATURED SEGMENT IN THE TRANSPLANT DIAGNOSTICS MARKET 88
FIGURE 33 ASIA-PACIFIC REGION IS THE THIRD LARGEST SEGMENT IN TRANSPLANT DIAGNOSTICS MARKET 97
FIGURE 34 LEADING MARKET PLAYERS ADOPTED STRATEGIC ACQUISITIONS AS THEIR KEY GROWTH STRATEGY DURING 2012–2014 108
FIGURE 35 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2013 109
FIGURE 36 GROWING NUMBER OF STRATEGIC ACQUISITIONS IS STIMULATING MARKET COMPETITION 110
FIGURE 37 GEOGRAPHIC REVENUE MIX OF THE TOP PLAYERS* 117
FIGURE 38 STRATEGIC BENCHMARKING: LEADING COMPANIES FOCUS ON TECHNOLOGICAL ADVANCEMENTS TO STRENGTHEN THEIR MARKET POSITION 118
FIGURE 39 STRATEGIC BENCHMARKING: THERMO FISHER SCIENTIFIC AGGRESSIVELY FOCUSES ON THE MARKET IN CHINA TO ADDRESS LOCAL DEMAND 119
FIGURE 40 THERMO FISHER SCIENTIFIC, INC. : COMPANY SNAPSHOT 120
FIGURE 41 IMMUCOR, INC.: COMPANY SNAPSHOT 125
FIGURE 42 QIAGEN N.V. : COMPANY SNAPSHOT 130
FIGURE 43 BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT 134
FIGURE 44 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT 138
FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 140
FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT 142


【レポートのキーワード】

臓器移植検査、移植検査技術、血清学的検査、混合リンパ球培養試験(MLC)、ポリメラーゼ連鎖反応(PCR)、次世代シーケンシング(NGS)、移植検査装置、サンガー法、移植検査試薬、消耗品、ソフトウェア、病院、医療機器

★調査レポート[臓器移植検査の世界市場:血清学的検査、混合リンパ球培養試験(MLC)、ポリメラーゼ連鎖反応(PCR)、次世代シーケンシング(NGS)] ( Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019 / MAM-BT-3266) 販売に関する免責事項
[臓器移植検査の世界市場:血清学的検査、混合リンパ球培養試験(MLC)、ポリメラーゼ連鎖反応(PCR)、次世代シーケンシング(NGS)] ( Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019 / MAM-BT-3266) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆